Is inflammatory micronucleation the key to a successful anti-mitotic cancer drug?
Paclitaxel is a successful anti-cancer drug that kills cancer cells in two-dimensional culture through perturbation of mitosis, but whether it causes tumour regression by anti-mitotic actions is controversial. Drug candidates that specifically target mitosis, including inhibitors of kinesin-5, AurkA...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Royal Society
2017-01-01
|
| סדרה: | Open Biology |
| נושאים: | |
| גישה מקוונת: | https://royalsocietypublishing.org/doi/pdf/10.1098/rsob.170182 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|